Bright Biotech Limited

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Bright Biotech Limited - overview

Established

2019

Location

Manchester, England, UK

Primary Industry

Biotechnology

About

Based in Manchester, UK, and founded in 2019, Bright Biotech Limited operates as a biotechnology company that provides contract manufacturing and development specializing in low-cost therapeutic proteins produced from plants. In November 2022, Bright Biotech Limited raised USD 3. 2 million in seed funding led by Foodlabs, with participation from other Big Idea Ventures, CPT Capital, and HackVentures Ltd. As of November 2022, Mohammad El Hajj is the Chief Operating Officer (CEO) of the company.


Bright Biotech Limited develops plant-based affordable fusion proteins for Research & development activities, therapeutic, biopharmaceutical, agri-food, and industrial uses, providing clients with sustainable, highly flexible, and efficient technology to support in research and development. The company plans to use the November 2022 funding to increase its workforce and grow its market by offering other products to its partners.


Current Investors

Foodlabs, Big Idea Ventures, CPT Capital

Primary Industry

Biotechnology

Sub Industries

Bioinformatics, Molecular Science, Genetics & Gene Therapy, Crop Production

Website

www.brightbiotech.co.uk

Verticals

Manufacturing

Company Stage

Angel & Seed

Total Amount Raised

Subscriber access only

Bright Biotech Limited - employee data

Blurred Background

Want to see Employee Count?

Request a demo for full access to this profile.

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.